Medikit Co.,Ltd. (TYO:7749)
Japan
· Delayed Price · Currency is JPY 2,529.00
-21.00 (-0.82%)
Jul 4, 2025, 3:00 PM JST
Medikit Revenue
In the fiscal year ending March 31, 2025, Medikit had annual revenue of 22.55B JPY with 3.22% growth. Medikit had revenue of 5.21B in the quarter ending March 31, 2025, with 4.43% growth.
Revenue
22.55B
Revenue Growth
+3.22%
P/S Ratio
1.64
Revenue / Employee
22.80M
Employees
989
Market Cap
36.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 22.55B | 703.00M | 3.22% |
| Mar 31, 2024 | 21.85B | 243.00M | 1.12% |
| Mar 31, 2023 | 21.61B | 1.48B | 7.34% |
| Mar 31, 2022 | 20.13B | 818.00M | 4.24% |
| Mar 31, 2021 | 19.31B | -581.00M | -2.92% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |